Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02905318
What this trial is testing

Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Canadian Cancer Trials Group 19
Large-scale testing (Phase 3)Active Not RecruitingNCT04647526
What this trial is testing

Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company 455
Not applicableStudy completedNCT02899104
What this trial is testing

Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 200
Not applicableStudy completedNCT04995614
What this trial is testing

Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223

Who this might be right for
Castrate Resistant Prostate CancerBone Metastases
Radboud University Medical Center 122
Large-scale testing (Phase 3)Active Not RecruitingNCT03732820
What this trial is testing

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 895
Very early researchLooking for participantsNCT05603559
What this trial is testing

177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 30
Large-scale testing (Phase 3)Study completedNCT01618370
What this trial is testing

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer 705
Early research (Phase 1)Ended earlyNCT03137758
What this trial is testing

A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pellficure Pharmaceuticals, Inc 12
Testing effectiveness (Phase 2)Looking for participantsNCT07594106
What this trial is testing

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 265
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Early research (Phase 1)Looking for participantsNCT06830850
What this trial is testing

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Atridia Pty Ltd. 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04446117
What this trial is testing

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Who this might be right for
Metastatic Prostate CancerProstate Adenocarcinoma
Exelixis 575
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT05502315
What this trial is testing

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerMetastatic Cancer
Rana McKay, MD 47
Not applicableActive Not RecruitingNCT04122976
What this trial is testing

A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described

Who this might be right for
Prostate Cancer
Bayer 805
Early research (Phase 1)Study completedNCT01594918
What this trial is testing

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Rahul Aggarwal 25
Testing effectiveness (Phase 2)Ended earlyNCT04159896
What this trial is testing

ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Barbara Ann Karmanos Cancer Institute 10
Not applicableStudy completedNCT03672396
What this trial is testing

Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerAndrogen Deprivation Therapy
UNC Lineberger Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02361086
What this trial is testing

Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerCRPC
Innocrin Pharmaceutical 21
Early research (Phase 1)Study completedNCT04428788
What this trial is testing

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Celgene 131
Next Page